Hired and Retired: Big pharma to biotech trend continues

Hired and Retired: Big pharma to biotech trend continues

As the stream of executives flowing from large pharma companies to smaller biotechs builds into torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling products, have made the move to become executives at a very early stage biotech that has […]

Residency reunites young MD with the doctor who delivered him

Residency reunites young MD with the doctor who delivered him

CLOSE Jacob was one of hundreds of newborns Dr. Ronald would deliver in his career. He had no idea their paths would cross again 26 years later. Humankind, USA TODAY Harrison’s residency program got underway this summer. Resident MD Jacob Van Fleet, left, who was born at the Naval Hospital in Bremerton, by doctor Ronald […]

Intensive One Day Programme: Drafting and Negotiating Clinical Trial Agreements 2018 (London, United Kingdom …

Intensive One Day Programme: Drafting and Negotiating Clinical Trial Agreements 2018 (London, United Kingdom …

DUBLIN–(BUSINESS WIRE)–Sep 20, 2018–The “Drafting and Negotiating Clinical Trial Agreements 2018” conference has been added to ResearchAndMarkets.com‘s offering. Clinical Trial Agreements (CTA) are one of the most important agreements in the pharma industry as no research can start without the right agreement in place between sponsor and host organisation. They provide a contract which manages […]

J&J files 'breakthrough' bladder cancer drug in US

J&J files 'breakthrough' bladder cancer drug in US

Johnson & Johnson has filed for approval of a new targeted bladder cancer therapy in the US, setting up a possible approval next year. The new drug candidate – selective fibroblast growth factor receptor inhibitor erdafitinib – is an oral, once daily treatment for the second-line treatment of patients with locally advanced or metastatic urothelial […]

Global Chip Antenna Market 2018 by Key Players : Polysciences, Inc., Asmee Chemicals, Forbes Pharmaceuticals

Global Chip Antenna Market Professional Survey Report 2018 revealed by QY Market Insights offers key market trends, industry drivers, challenges, opportunities, upcoming technologies, key company profiles and strategies of players such as Ricca Chemical, AMRESCO, Polysciences, Inc., Asmee Chemicals, Forbes Pharmaceuticals, LabChem Inc, Alfa Aesar, Ricca Chemical Company, NBS Biologicals, Hunan Chemical BV, JQC(Huayin) Pharmaceutical […]

Merrimack Pharma (MACK) Receives $5M Milestone Payment from Shire

Merrimack Pharma (MACK) Receives $5M Milestone Payment from Shire

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) received a $5 million milestone payment from Shire (NASDAQ: SHPG), triggered by the sale of ONIVYDE in the first major non-European, non-Asian country, pursuant to the terms of Merrimack’s asset sale to Ipsen in 2017. “Since the […]

Math Meets Medicine

Math Meets Medicine

click to enlarge Thousands of times every day, doctors around the world look for issues inside their patients without ever breaking the skin, thanks to help from imaging technology like computed tomography (CT) scans, magnetic resonance imaging (MRI), X-ray and ultrasound. But those machines can be expensive, running from hundreds to thousands of […]

Relmada doses 25% of subjects in Phase ll trial of dextromethadone

Relmada doses 25% of subjects in Phase ll trial of dextromethadone

Relmada Therapeutics has completed dosing of 25% of the planned subjects in its Phase ll clinical trial of dextromethadone (REL-1017) to treat patients with major depressive disorder. The dosing for the trial commenced in June last year and has not caused any of the patients treated with REL-1017 to experience serious adverse events or psychotomimetic […]

DOOR Syndrome / Rare Genetic Disorder

DOOR Syndrome / Rare Genetic Disorder

DOOR syndrome is a rare congenital (observed at birth) condition involving numerous anatomic and developmental abnormalities. The incidence of DOOR syndrome is rare with only 50 people known to be affected globally. DOOR is an acronym for “deafness, onychodystrophy (short or no nails), osteodystrophy (short toes and fingers), and mental retardation“. With the inclusion of […]

1 2 3 1,957